171 related articles for article (PubMed ID: 26103543)
1. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
Danve AS; Kulkarni S
Am J Ther; 2017 May; 24(3):e347-e350. PubMed ID: 26103543
[TBL] [Abstract][Full Text] [Related]
2. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Llorca J
Ann N Y Acad Sci; 2010 Apr; 1193():153-9. PubMed ID: 20398022
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
Gonzalez-Gay MA; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
Clin Exp Rheumatol; 2006; 24(1):83-6. PubMed ID: 16539824
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis, insulin resistance, and diabetes.
Nicolau J; Lequerré T; Bacquet H; Vittecoq O
Joint Bone Spine; 2017 Jul; 84(4):411-416. PubMed ID: 27777170
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA.
González-Gay MA; González-Juanatey C
Nat Rev Rheumatol; 2012 Nov; 8(11):641-2. PubMed ID: 23007743
[No Abstract] [Full Text] [Related]
7. Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis.
Cugno M; Ingegnoli F; Gualtierotti R; Fantini F
Curr Vasc Pharmacol; 2010 Mar; 8(2):285-92. PubMed ID: 19485909
[TBL] [Abstract][Full Text] [Related]
8. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.
Rosenvinge A; Krogh-Madsen R; Baslund B; Pedersen BK
Scand J Rheumatol; 2007; 36(2):91-6. PubMed ID: 17476613
[TBL] [Abstract][Full Text] [Related]
10. Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis.
Costa NT; Veiga Iriyoda TM; Kallaur AP; Delongui F; Alfieri DF; Lozovoy MA; Amin RB; Delfino VD; Dichi I; Simão AN
Oxid Med Cell Longev; 2016; 2016():8962763. PubMed ID: 27340510
[TBL] [Abstract][Full Text] [Related]
11. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma.
Sarzi-Puttini P; Atzeni F; Shoenfeld Y; Ferraccioli G
Autoimmun Rev; 2005 Mar; 4(3):153-61. PubMed ID: 15823501
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis as a mechanism of action of tumor necrosis factor antagonists in rheumatoid arthritis.
Makrygiannakis D; Catrina AI
J Rheumatol; 2012 Apr; 39(4):679-85. PubMed ID: 22422498
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
[TBL] [Abstract][Full Text] [Related]
16. Effect of Systemic Inflammation on the Function of Insulin and Glucose Metabolism in Rheumatoid Arthritis.
Herlitz-Cifuentes HS; Garces PC; Fernandez LI; Guzman-Gutierrez EA
Curr Diabetes Rev; 2015; 12(2):156-62. PubMed ID: 26033386
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.
Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
Avouac J; Allanore Y
Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
[TBL] [Abstract][Full Text] [Related]
19. Accelerated Atherosclerosis in Rheumatoid Arthritis: Mechanisms and Treatment.
Reiss AB; Silverman A; Khalfan M; Vernice NA; Kasselman LJ; Carsons SE; De Leon J
Curr Pharm Des; 2019; 25(9):969-986. PubMed ID: 31208307
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid Arthritis - Anti-TNF.
Chaabo K; Kirkham B
Int Immunopharmacol; 2015 Aug; 27(2):180-4. PubMed ID: 25962818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
